Bestatin
(Synonyms: 乌苯美司; Ubenimex) 目录号 : GC11780
Bestatin是氨基肽酶N(APN/CD13)抑制剂,其IC50值为14.9±3.4μM。
Cas No.:58970-76-6
Sample solution is provided at 25 µL, 10mM.
Bestatin is known to be an inhibitor of Aminopeptidase N (APN/CD13), which has the IC50 values of 14.9±3.4μM[1]. Bestatin can also inhibits aminopeptidase B and LTA4 hydrolase[2, 3]. Bestatin was shown to enhance antibody-dependent cell mediated cytotoxicity and natural killer cell activity[4].
Bestatin (10μM; 24h) significantly reduced melflufen (125 or 250nM; 24h) induced cytotoxicity in AMOaBTZ cells[5]. Bestatin (0.25mM; 24h) can inhibit the migration and proliferation of breast cancer cells[6].
Bestatin (30mg/kg; i.p. ; 15min) alleviated the acute lung injury in one-lung ventilation model rats[7]. Bestatin (0.1 or 1 or 10mg/kg; i.p. ; 5 or 10 times at 24h intervals) potentiated the humoral response to sheep erythrocytes (SRBC; i.p. ) suspension in mice, resulting in an increased number of plaque-forming cells[8].
References:
[1] LUAN Y, MA C, SUI Z, et al. LYP3, a new bestatin derivative for aminopeptidase N inhibition [J]. Med Chem, 2011, 7(1): 32-6.
[2] JIA M R, WEI T, XU W F. The Analgesic Activity of Bestatin as a Potent APN Inhibitor [J]. Front Neurosci, 2010, 4(50.
[3] AOZUKA Y, KOIZUMI K, SAITOH Y, et al. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice [J]. Cancer Lett, 2004, 216(1): 35-42.
[4] SCORNIK O A, BOTBOL V. Bestatin as an experimental tool in mammals [J]. Current drug metabolism, 2001, 2(1): 67-85.
[5] BYRGAZOV K, BESSE A, KRAUS M, et al. Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells [J]. Hemasphere, 2021, 5(7): e602.
[6] MA Y, YANG X, PAN P, et al. Bestatin attenuates breast cancer stemness by targeting puromycin-sensitive aminopeptidase [J]. Discov Oncol, 2024, 15(1): 197.
[7] LUO J, MA Q, TANG H, et al. LTB4 Promotes Acute Lung Injury via Upregulating the PLCepsilon-1/TLR4/NF-kappaB Pathway in One-Lung Ventilation [J]. Dis Markers, 2022, 2022(1839341.
[8] LIS M, SZCZYPKA M, SUSZKO A, et al. The effects of bestatin on humoral response to sheep erythrocytes in non-treated and cyclophosphamide-immunocompromised mice [J]. Immunopharmacol Immunotoxicol, 2013, 35(1): 133-8.
Bestatin是氨基肽酶N(APN/CD13)抑制剂,其IC50值为14.9±3.4μM[1]。Bestatin还能抑制氨基肽酶B和LTA4水解酶[2,3]。Bestatin可增强抗体依赖细胞介导的细胞毒性和自然杀伤细胞活性[4]。
Bestatin(10μM; 24h)显著削弱了melflufen(125 or 250nM; 24h)诱导的AMOaBTZ细胞毒性[5]。Bestatin(0.25mM; 24h)可抑制乳腺癌细胞的迁移和增殖[6]。
使用Bestatin(30mg/kg; i.p. ; 15min)处理单肺通气模型大鼠,Bestatin可减轻大鼠急性肺损伤[7]。使用Bestatin(0.1 or 1 or 10mg/kg; i.p. ; 5 or 10 times at 24h intervals)处理使用SRBC(sheep erythrocytes,绵羊红细胞;i.p.)悬液免疫的小鼠,Bestatin增强了小鼠对SRBC悬液的体液免疫反应,产生更多的空斑形成细胞[8]。
Cell experiment [1]: | |
Cell lines | Mammary breast cancer cell lines SKRB3 |
Preparation Method | SKRB3 were cultured in McCoy’s 5A supplemented with 10% fetal bovine serum at 37°C in a humidified 5% CO2 atmosphere. Cells were cultured until they were 70% confluent in 6‑well plate, then a wound was drawn by a sterile 200μl pipette tip. Subsequently, cells were cultured in fresh serum-free medium with/without 0.25mM Bestatin for 24h. |
Reaction Conditions | 0.25mM; 24h |
Applications | Bestatin can inhibit the migration and proliferation of breast cancer cells. |
Animal experiment [2]: | |
Animal models | male and female Balb/c mice |
Preparation Method | The mice were immunized intraperitoneally with 0.2ml of 10% SRBC suspension (4×108 cells per mouse). The blood was taken from the jugular vein of cross-bred clinically healthy sheep. The sheep blood was collected in sterile manner into Alsever’s solution containing glucose (2.05%), sodium citrate (0.8%), sodium chloride (0.42%), and citric acid (0.055%) and kept there at 4℃ for at least 3 days. The SRBC suspension was prepared extempore in phosphate-buffered saline (PBS). Bestatin was dissolved in PBS. The agent (doses of 10, 1, and 0.1mg/kg) was injected i.p. to mice, 5 or 10 times at 24h intervals before SRBC immunization. The mice were immunized 24h after the last dose of bestatin. |
Dosage form | 0.1 or 1 or 10mg/kg; i.p. ; 5 or 10 times at 24h intervals |
Applications | Bestatin potentiated the humoral response to sheep erythrocytes in mice, resulting in an increased number of plaque-forming cells and 2-mercaptoethanol-resistant anti-SRBC hemagglutinations. |
References: |
Cas No. | 58970-76-6 | SDF | |
别名 | 乌苯美司; Ubenimex | ||
化学名 | (2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid | ||
Canonical SMILES | CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O | ||
分子式 | C16H24N2O4 | 分子量 | 308.37 |
溶解度 | ≥ 12.34mg/mL in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 3.2429 mL | 16.2143 mL | 32.4286 mL |
5 mM | 0.6486 mL | 3.2429 mL | 6.4857 mL |
10 mM | 0.3243 mL | 1.6214 mL | 3.2429 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet